WORLD

FDA approves Pfizer booster for older, at-risk people in U.S.

A medical worker prepares a dose of the Pfizer-BioNTech vaccine in San Francisco on Aug. 1. After weeks of internal strife at the U.S. Food and Drug Administration, the agency on Wednesday authorized people over 65 who had received Pfizer-BioNTech's coronavirus vaccine to get a booster shot at least six months after their second injection. | MIKE KAI CHEN / THE NEW YORK TIMES

BLOOMBERG

Sep 23, 2021

People over age 65 and adults at high risk of severe COVID-19 can receive a booster dose of the Pfizer Inc.-BioNTech SE vaccine, the Food and Drug Administration said, opening a new and more controversial phase of the U.S. immunization campaign.

The emergency-use authorization also allows boosters for people 18 and older whose occupational exposure to the SARS-CoV-2 virus puts them at elevated risk of serious complications. Booster doses can be given any time at least six months after a person received their second shot, the FDA said in a statement.

Acting FDA Commissioner Janet Woodcock said the authorization would allow people such as teachers and day-care staff, as well as health care and grocery workers, to get the third shot.

FDA approves Pfizer booster for older, at-risk people in U.S.

In your social network

In your inbox

In your social network

In your inbox